Which has the lower trailing P/E, BSX or CI?

CI has the lower trailing P/E: BSX trades at 17.86 and CI at 11.93. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BSX or CI?

Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus CI at 11.11%.

Does BSX or CI pay a bigger dividend?

CI pays a dividend (2.20% yield), while BSX has no payments in the available dividend history.

Is BSX or CI more profitable?

BSX runs the higher net margin — BSX at 17.47% versus CI at 2.27%.

How have BSX and CI total returns compared?

Over the past 10 years, BSX delivered 6.22% and CI delivered 9.29% annualized total return. Past performance doesn't predict future results.

Boston Scientific Corporation (BSX) vs Cigna Corporation (CI)

A side-by-side comparison of Boston Scientific Corporation and Cigna Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

BSX

Boston Scientific Corporation

$65.30B

$43.93HealthcareDelayed quote: Sep 15, 2026, 10:30 AM EDT

Cigna Corporation

$76.15B

$288.18HealthcareDelayed quote: Sep 15, 2026, 10:30 AM EDT

Total return — BSX vs CI

growth of $100 · dividends reinvested · last 10y

BSX +82.8% (+6.2%/yr)CI +144.7% (+9.4%/yr)CI compounded faster over this window

BSX CI

BSX vs CI: by the numbers

•CI is the larger company ($76.15B vs $65.30B market cap).
•CI trades at the lower trailing earnings multiple (11.93 vs 17.86 P/E), one valuation lens rather than an overall verdict.
•BSX converts more revenue to profit (17.47% vs 2.27% net margin).
•BSX grew revenue faster over the past five years (13.40% vs 11.11% CAGR).
•CI pays a dividend (2.20% yield), while BSX has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	BSX	CI
P/E ratio	17.86	11.93
Forward P/E	13.36	9.45
P/S ratio	3.11	0.27
P/B ratio	2.62	1.79
EV / EBITDA	13.35	8.24
FCF yield	5.55%	11.97%

Profitability

Metric	BSX	CI
Gross margin	71.16%	11.66%
Operating margin	21.46%	3.46%
Net margin	17.47%	2.27%
ROE	14.71%	15.05%
ROIC	10.57%	7.69%

Dividends

Metric	BSX	CI
Dividend yield	N/A	2.20%
Payout ratio	N/A	25.62%

Growth (annualized)

Metric	BSX	CI
Revenue CAGR (5Y)	13.40%	11.11%
EPS CAGR (5Y)	N/A	-0.76%
FCF CAGR (5Y)	15.64%	-1.95%
Total return CAGR (5Y)	-0.67%	8.52%

Frequently asked

Which has the lower trailing P/E, BSX or CI?: CI has the lower trailing P/E: BSX trades at 17.86 and CI at 11.93. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BSX or CI?: Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus CI at 11.11%.
Does BSX or CI pay a bigger dividend?: CI pays a dividend (2.20% yield), while BSX has no payments in the available dividend history.
Is BSX or CI more profitable?: BSX runs the higher net margin — BSX at 17.47% versus CI at 2.27%.
How have BSX and CI total returns compared?: Over the past 10 years, BSX delivered 6.22% and CI delivered 9.29% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BSX analysis Full CI analysis Interactive comparison tool

Dig into the metrics

Boston Scientific P/E ratio Cigna P/E ratio Cigna dividend yield Boston Scientific ROE Cigna ROE Boston Scientific operating margin Cigna operating margin Boston Scientific revenue growth Cigna revenue growth Boston Scientific free cash flow Cigna free cash flow

Boston Scientific & Cigna appear in these rankings

Highest Dividend Yield Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.